This webinar will delve into the recent updates to the Q14 and Q2(R2) guidelines, providing a comprehensive understanding of their impact on analytical procedures in the pharmaceutical industry. Through interactive presentations and practical examples, attendees will gain valuable insights into:

• The scientific and risk-based approach emphasized in the revised guidelines.
• Developing robust and efficient analytical procedures aligned with the Analytical Target Profile.
• Implementing a risk-based validation strategy that focuses on critical aspects.
• Ensuring compliance with the latest regulatory requirements.

This webinar benefits the following agencies:

• Pharmaceutical companies
• Contract research organizations (CROs)
• Regulatory agencies
• Biopharmaceutical companies

Who Should Attend?

This webinar is ideal for working professionals involved in the development, validation, and implementation of analytical procedures for drugs, including:

• Analytical chemists
• Quality control personnel
• Regulatory affairs specialists
• Drug development scientists
• Research scientists